White label ELPA - ClinicalTrials.eu

Study on Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan for Adults with Prostate Cancer

Recruiting

3 1 1 1
Investigated Drugs:
- Lutetium (177Lu) Vipivotide Tetraxetan
+4
Study of Lutetium (177Lu) Vipivotide Tetraxetan for Patients with High-Risk Localized or Locally Advanced Prostate Cancer Eligible for Surgery

Recruiting

1 1 1 1
Investigated Drugs:
- Lutetium (177Lu) Vipivotide Tetraxetan
Study on Optimizing CDK 4/6 Inhibitors and Endocrine Therapy for Older Patients with Advanced Breast Cancer Using Abemaciclib, Palbociclib, and Ribociclib

Recruiting

3 1 1 1
Investigated Diseases:
- Breast cancer
Investigated Drugs:
Study on Lasofoxifene, Fulvestrant, and Abemaciclib for Advanced Breast Cancer in Women and Men with ESR1 Mutation

Recruiting

3 1 1
Investigated Diseases:
- Breast cancer metastatic
Investigated Drugs:
+2
Study on Optimizing Treatment for Chronic Heart Failure with Reduced Ejection Fraction Using Nebivolol and a Drug Combination

Recruiting

3 1 1 1
Investigated Drugs:
Study on Reducing Rituximab Dosage for Patients with Rheumatoid Arthritis

Recruiting

3 1 1 1
Investigated Diseases:
- Rheumatoid arthritis
Investigated Drugs:
- Rituximab
Study on Zilucoplan Sodium for Children Aged 2 to 17 with Generalized Myasthenia Gravis

Recruiting

4 1 1 1
Investigated Diseases:
- Myasthenia gravis
Investigated Drugs:
- Zilucoplan Sodium
- ZILUCOPLAN
Study on Ibrutinib and Venetoclax for Patients with Untreated Chronic Lymphocytic Leukemia

Recruiting

2 1 1 1
Investigated Drugs:
- Ibrutinib
- Venetoclax
Study on Efruxifermin for Patients with Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH) and Fibrosis

Recruiting

3 1
Investigated Diseases:
- Hepatic fibrosis
Investigated Drugs:
- Efruxifermin
Study on Long-Term Safety of Inclisiran for Patients with Familial Hypercholesterolemia Who Completed Previous Adolescent Studies

Recruiting

3 1 1 1
Investigated Drugs:
- Inclisiran
+6

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies